The Carter Center   Report issue

Foundation Phase 4
Founded: Atlanta GA United States (1982)

Organization Overview

First Clinical Trial
2015
NCT02754583
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

The Carter Center | The Carter Center Ethiopia

Active Ingredients

Drugs in Phase 4 Trials (3)

albendazole (Albenza) (1 trial)

azithromycin (zithromax) (5 trials)

tetracycline (tetrex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Trachoma (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 3